🇺🇸 FDA
Pipeline program

Trodelvy 200 mg powder for concentrate for solution for infusion

IMMU-132-11

Phase 2 small_molecule active

Quick answer

Trodelvy 200 mg powder for concentrate for solution for infusion for Metastatic Solid Tumors is a Phase 2 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences International Limited
Indication
Metastatic Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials